Articles related to DEPRESSION

Explore the intricate landscape of depression, from its genetic underpinnings to innovative treatment approaches. This guide offers physicians a comprehensive overview, aiding in the diagnosis, treatment, and prevention of this pervasive mood disorder.

The FDA’s approval of Zurzuvae (zuranolone) as the first oral treatment for postpartum depression represents a significant advancement in patient care. Physicians are encouraged to explore this new option, considering both its proven efficacy and accompanying warnings, to provide more accessible care for those struggling with this serious condition.

A recent study on bipolar I depression patients found that extended antidepressant maintenance for 52 weeks did not significantly prevent mood episode relapses compared to an 8-week regimen.

The study on the use of subcutaneous racemic ketamine in treatment-resistant depression underscores the significance of a flexible, individualized dosing approach over a 4-week course.

Exploring new avenues for treating depression in youth, this compelling research showcases the potential of physical activity interventions in significantly reducing depressive symptoms, particularly among those aged 13 years and above. Find out how this accessible, non-pharmacological approach could transform pediatric mental health care.

Explore the recent identification of two distinct neurophysiological subtypes of major depressive disorder, a key advancement that could refine your approach to personalized treatments in mental health.